Press Releases

01.05.2021 | Nanion Technologies and InnoVitro

Munich, Germany, May 1st 2021:

Assessing preclinical cardiac contractility without animal use, but with human iPSC-derived cardiomyocytes is not only attractive for people in the cardiac community!

Parliamentary State Secretary Thomas Rachel (representing the Federal Ministry of Education & Research) stopped by InnoVitro headquarters in Juelich to award them with a 200k grant for the support of the new project SMOOTH: “Semi–synthetic Muscle Organoids based On Tissue Hybrids”

Read the full press release in German here.

Back to Overview

 

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.